title: Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line.
abstract: In the present paper, we investigated the involvement of cryptococcal melanogenesis and macrophage nitric oxide (NO) production in the accomplishment of anticryptococcal activity by microglial effector cells, using the murine cell line BV-2. We demonstrate that the constitutive levels of anticryptococcal activity exerted by BV-2 cells is significantly enhanced upon interferon gamma plus lipopolysaccharide treatment. The phenomenon, which occurs with no enhancement of phagocytic activity, is associated with the production of high levels of NO and is abolished by addition of NG-monomethyl-L-arginine. Comparable patterns of results are observed employing either unopsonized or opsonized microbial targets, the latter microorganisms being markedly more susceptible to BV-2 cell antimicrobial activity. Furthermore, melanization of Cryptococcus neoformans significantly reduces its susceptibility to BV-2 antimicrobial activity, regardless of the fact that activated macrophages or opsonized microorganisms have been employed. In conclusion, our results provide evidence that NO-dependent events are involved in the fulfillment of anticryptococcal activity by activated microglial cells and that fungal melanization is a precious escamotage through which C. neoformans overcomes host defenses.
authors.affiliation: Department of Biomedical Sciences, University of Modena, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Blasi
authors.forename: R
authors.initials: R
authors.lastname: Barluzzi
authors.forename: R
authors.initials: R
authors.lastname: Mazzolla
authors.forename: B
authors.initials: B
authors.lastname: Tancini
authors.forename: S
authors.initials: S
authors.lastname: Saleppico
authors.forename: M
authors.initials: M
authors.lastname: Puliti
authors.forename: L
authors.initials: L
authors.lastname: Pitzurra
authors.forename: F
authors.initials: F
authors.lastname: Bistoni
mesh_terms: D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002460:Cell Line; D003455:Cryptococcus neoformans / Q000276:immunology*; D016259:Genes, myc; D007371:Interferon-gamma / Q000494:pharmacology*; D051379:Mice; D017628:Microglia / Q000187:drug effects / Q000276:immunology / Q000382:microbiology*; D009569:Nitric Oxide / Q000502:physiology*; D027384:Oncogene Proteins v-raf; D010587:Phagocytosis / Q000187:drug effects; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D011994:Recombinant Proteins; D012190:Retroviridae; D015682:Retroviridae Proteins, Oncogenic / Q000235:genetics; D014162:Transfection; D019323:omega-N-Methylarginine
chemical_list: D011994:Recombinant Proteins; D015682:Retroviridae Proteins, Oncogenic; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D007371:Interferon-gamma; D001120:Arginine; D011505:Protein-Tyrosine Kinases; D027384:Oncogene Proteins v-raf